Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

[1]  A. Børresen-Dale,et al.  Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study , 2010, Breast Cancer Research and Treatment.

[2]  U. Bick,et al.  Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  V. Beral,et al.  Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis , 2009, British Journal of Cancer.

[4]  B. Henderson,et al.  Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[5]  Christopher I Amos,et al.  Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Begg,et al.  Variation of breast cancer risk among BRCA1/2 carriers. , 2008, JAMA.

[7]  C. Begg,et al.  Reproductive History and Risk of Second Primary Breast Cancer: The WECARE Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  Douglas F. Easton,et al.  Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  J. Klijn,et al.  Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. , 2007, European journal of cancer.

[10]  A. Whittemore,et al.  BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays , 2007, The American journal of surgical pathology.

[11]  F. Couch,et al.  Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers , 2007, Breast Cancer Research and Treatment.

[12]  M. Pike,et al.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies , 2006, Breast Cancer Research.

[13]  J. Chang-Claude,et al.  Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). , 2006, Journal of the National Cancer Institute.

[14]  F. Couch,et al.  Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers , 2005, International journal of cancer.

[15]  O. Olopade,et al.  Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers , 2005, Cancer Causes & Control.

[16]  Julian Peto,et al.  Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype , 2005, Clinical Cancer Research.

[17]  Päivi Heikkilä,et al.  Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families , 2004, Breast Cancer Research.

[18]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  D. Horsman,et al.  Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of the National Cancer Institute.

[20]  Ellen Warner,et al.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  William D. Foulkes,et al.  Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .

[22]  Å. Borg,et al.  Reproductive factors in hereditary breast cancer , 1999, Breast Cancer Research and Treatment.

[23]  S. Schwartz,et al.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States) , 1996, Cancer Causes & Control.

[24]  L. Bégin,et al.  Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. , 2004, Journal of the National Cancer Institute.

[25]  Bryan Langholz,et al.  Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study , 2004, Breast Cancer Research.

[26]  P. Porter,et al.  Epidemiologic and molecular risk factors for contralateral breast cancer among young women , 2003, British Journal of Cancer.

[27]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Jónasson,et al.  BRCA2 mutation carriers, reproductive factors and breast cancer risk , 2003, Breast cancer research : BCR.

[29]  A. Børresen-Dale,et al.  Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.

[30]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[31]  P. Hartge,et al.  Breast Cancer Risk in Ashkenazi BRCA1/2 Mutation Carriers: Effects of Reproductive History , 2002, Epidemiology.

[32]  M. J. van de Vijver,et al.  The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  R. Goldbohm,et al.  Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease , 2002 .

[34]  K. Hemminki,et al.  Risk factors and age‐incidence relationships for contralateral breast cancer , 2000, International journal of cancer.

[35]  W. Thompson,et al.  Epidemiology of contralateral breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  G. Giles,et al.  Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. , 1999, Cancer research.

[37]  Bryan Langholz,et al.  Methods for the Analysis of Sampled Cohort Data in the Cox Proportional Hazards Model , 1995 .

[38]  Bryan Langholz,et al.  Counter-matching: A stratified nested case-control sampling method , 1995 .

[39]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.

[40]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.

[41]  N. Risch,et al.  Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. , 1992, American journal of epidemiology.

[42]  A. Jacobsen,et al.  Adjuvant radiotherapy and risk of contralateral breast cancer. , 1992, Journal of the National Cancer Institute.

[43]  Thompson Wd,et al.  RISK OF CONTRALATERAL BREAST CANCER: ASSOCIATIONS WITH FACTORS RELATED TO INITIAL BREAST CANCER , 1988 .

[44]  W. Thompson,et al.  Risk of contralateral breast cancer: associations with factors related to initial breast cancer. , 1988, American journal of epidemiology.